Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

8.93
Delayed Data
As of Sep 01
 -0.04 / -0.45%
Today’s Change
4.58
Today|||52-Week Range
13.50
+53.97%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close8.97
Today’s open8.61
Day’s range7.85 - 9.40
Volume148,385
Average volume (3 months)33,429
Market cap$99.6M
Dividend yield--
Data as of 09/01/2015

Growth & Valuation

Earnings growth (last year)-125.51%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.17

Competitors

 Today’s
change
Today’s
% change
CLCDCoLucid Pharmaceutic...-0.43-6.56%
CPIXCumberland Pharmaceu...+0.06+1.00%
XOMAXOMA Corp-0.05-6.10%
ZSANZosano Pharma Corp0.000.00%
Data as of 09/01/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$9.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers